AI summary · may contain errors
In adults with cirrhosis at high risk for hepatocellular carcinoma, HelioLiver Dx detected 47.8% of HCC lesions overall and 28.6% of lesions ≤2 cm.
- Open access
- 11 cites
Moving in Journal of Hepatology.
Rebuilt
AI summary · may contain errors
In adults with cirrhosis at high risk for hepatocellular carcinoma, HelioLiver Dx detected 47.8% of HCC lesions overall and 28.6% of lesions ≤2 cm.
Newest first · last 60 days
AI summary · may contain errors
In orthotopic hepatocellular carcinoma models, GPC3-targeted paired PET imaging and alpha therapy achieved strong tumor uptake (>200 %IA/g) and excellent local control after a single 9.3 kBq dose.
AI summary · may contain errors
PTC596 controls H22 and Hepa1-6 hepatocellular carcinoma tumor growth in Balb/c and C57BL/6 mice and, with anti-PD-1, prolongs survival.
AI summary · may contain errors
Targeting ERO1A in liver cancer increases CD8+ T-cell infiltration and antitumor immune activity, linked to CCL4 upregulation and type I interferon pathway activation.
AI summary · may contain errors
High baseline circulating γδ T cells and early expansion of circulating CD8+PD-1+ T cells predict better outcomes with atezolizumab-bevacizumab in first-line hepatocellular carcinoma.
AI summary · may contain errors
Primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma is linked to markedly worse overall survival (AB-real: 7.3 vs 31.5 months).
AI summary · may contain errors
Aripiprazole prevents progression of MASH-induced hepatocellular carcinoma in rats, linked to antifibrogenic and anti-inflammatory modulation of liver fibroblasts and macrophages.
AI summary · may contain errors
MERP-pre and MERP-post MRI-based models predict 1-year very early recurrence after curative resection of single BCLC 0/A hepatocellular carcinoma, with C-index 0.685–0.790 across test cohorts.
AI summary · may contain errors
SOAT1 is significantly upregulated in hepatocellular carcinoma tumors and is linked to increased tumorigenicity and immune-evasive characteristics.
AI summary · may contain errors
Low Glul expression in CTNNB1-mutated hepatocellular carcinoma is linked to poor patient survival, highlighting glutamine synthetase as a key metabolic marker in this HCC subtype.
AI summary · may contain errors
A Translational Liver Cancer (TLC) Consortium framework defines four phases for developing, validating, and implementing hepatocellular cancer risk stratification models, from internal testing to impact evaluation.
AI summary · may contain errors
A composite CT radiomic GTR-ITH score predicts treatment response and overall survival in 742 patients with unresectable HCC receiving first-line TACE-ICI-MTT, with OR 34.39 and HR 0.63.
AI summary · may contain errors
In noncirrhotic steatotic liver disease within the US Veterans Affairs system, the SAFE score best predicted 10-year cirrhosis risk, with a threshold of 29.5 mapping to 2.5% risk.
AI summary · may contain errors
Transarterial radioembolization monotherapy is the only hepatocellular carcinoma (HCC) macrovascular invasion option with consistently low heterogeneity, yielding pooled 1-year overall survival of 34% (95% CI 20%–48%).
Journals this month
Topics moving, week to 17 Nov 2026
By field